I am an experienced Patient Safety Director, Risk Manager, and Nursing Professional with a strong track record of promoting a culture of safety, compliance, and quality healthcare. I am adept at independently managing multiple priorities, conducting in-depth analyses, and fostering a patient-centered environment. I have a demonstrated proficiency in risk management, process improvement, and driving positive outcomes.

Background

Patient Safety & Risk Management

Accomplishments

Managed the Telemetry Monitoring Program, ensuring compliance through consistent collaboration with frontline staff and leaders to implement improvement suggestions. Achieved top compliance among 14 facilities in the division and maintained zero Adverse Events related to Telemetry Monitoring during my tenure.

Regulatory Compliance

Oversaw the risk management program, ensuring compliance with statutory mandates, regulatory requirements, and accreditation standards.

• Served as the point person for regulatory agencies, including The Joint Commission and Florida Department of Health Agency for Healthcare Administration.

• Acted as the hospital spokesperson for ethical or regulatory concerns, conducting investigations into claims of deficiency and providing written responses with corrective actions.

• Conducted compliance audits of clinical care, environment, and policy adherence, collaborating with leaders and frontline staff to ensure constant regulatory readiness.

Led a successful opioid safety process improvement initiative, achieving top compliance in the division and zero Adverse Events related to Opioid Safety since 2020 through collaborative efforts with leaders and staff.

Medical Oncology Nursing Director

As a liaison between interdisciplinary team members, patients, and families, I ensured the delivery of services that consistently met and exceeded expectations. This resulted in a remarkable 24% year-over-year improvement in the Overall Patient Experience, and no formal grievances were filed for over nine months.

Facilitation of the implementation and completion of the elements of the annual HCA Risk Reduction Program beginning with the 2021 program.

Assessed and prioritized opportunities for effective changes while evaluating outcomes of process improvement activities. Revamped the direct admission process for patients needing acute inpatient care during chemotherapy, resulting in reduced admission wait times, minimized delays in chemotherapy administration, and decreased fiscal waste.

Established and maintained a high-functioning team, resulting in improved unit-based retention and meeting productivity targets. Achieved a remarkable 74.3% year-over-year reduction in RN turnover and successfully decreased Contract Labor by 70.7%, reaching zero. Additionally, addressed staff's work-life balance concerns by reducing overtime to less than 4%.